These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2016715)

  • 1. Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
    Tanaka H; Baba M; Ubasawa M; Takashima H; Sekiya K; Nitta I; Shigeta S; Walker RT; De Clercq E; Miyasaka T
    J Med Chem; 1991 Apr; 34(4):1394-9. PubMed ID: 2016715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
    Tanaka H; Baba M; Hayakawa H; Sakamaki T; Miyasaka T; Ubasawa M; Takashima H; Sekiya K; Nitta I; Shigeta S
    J Med Chem; 1991 Jan; 34(1):349-57. PubMed ID: 1992136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity.
    Tanaka H; Takashima H; Ubasawa M; Sekiya K; Nitta I; Baba M; Shigeta S; Walker RT; De Clercq E; Miyasaka T
    J Med Chem; 1992 Jan; 35(2):337-45. PubMed ID: 1732552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
    Tanaka H; Takashima H; Ubasawa M; Sekiya K; Nitta I; Baba M; Shigeta S; Walker RT; De Clercq E; Miyasaka T
    J Med Chem; 1992 Dec; 35(25):4713-9. PubMed ID: 1469700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel 6-substituted acyclouridine derivatives and their anti-HIV-1 activity.
    Tanaka H; Baba M; Ubasawa M; Takashima H; Sekiya K; Nitta I; Walker RT; De Clereq E; Miyasaka T
    Nucleic Acids Symp Ser; 1990; (22):127-8. PubMed ID: 2101894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
    Tanaka H; Takashima H; Ubasawa M; Sekiya K; Inouye N; Baba M; Shigeta S; Walker RT; De Clercq E; Miyasaka T
    J Med Chem; 1995 Jul; 38(15):2860-5. PubMed ID: 7636846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
    Tanaka H; Baba M; Saito S; Miyasaka T; Takashima H; Sekiya K; Ubasawa M; Nitta I; Walker RT; Nakashima H
    J Med Chem; 1991 Apr; 34(4):1508-11. PubMed ID: 2016729
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivatives.
    Baba M; De Clercq E; Iida S; Tanaka H; Nitta I; Ubasawa M; Takashima H; Sekiya K; Umezu K; Nakashima H
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2358-63. PubMed ID: 2088190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and potent anti-HIV-1 activity of novel 6-benzyluracil analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
    Danel K; Larsen E; Pedersen EB; Vestergaard BF; Nielsen C
    J Med Chem; 1996 Jun; 39(12):2427-31. PubMed ID: 8691437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
    Miyasaka T; Tanaka H; Baba M; Hayakawa H; Walker RT; Balzarini J; De Clercq E
    J Med Chem; 1989 Dec; 32(12):2507-9. PubMed ID: 2479745
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.
    Buckheit RW; Fliakas-Boltz V; Yeagy-Bargo S; Weislow O; Mayers DL; Boyer PL; Hughes SH; Pan BC; Chu SH; Bader JP
    Virology; 1995 Jun; 210(1):186-93. PubMed ID: 7540784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
    Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of human serum on the in vitro anti-HIV-1 activity of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives as related to their lipophilicity and serum protein binding.
    Baba M; Yuasa S; Niwa T; Yamamoto M; Yabuuchi S; Takashima H; Ubasawa M; Tanaka H; Miyasaka T; Walker RT
    Biochem Pharmacol; 1993 Jun; 45(12):2507-12. PubMed ID: 8328988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
    Baba M; De Clercq E; Tanaka H; Ubasawa M; Takashima H; Sekiya K; Nitta I; Umezu K; Walker RT; Mori S
    Mol Pharmacol; 1991 Jun; 39(6):805-10. PubMed ID: 1711148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase.
    Baba M; De Clercq E; Tanaka H; Ubasawa M; Takashima H; Sekiya K; Nitta I; Umezu K; Nakashima H; Mori S
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2356-60. PubMed ID: 1706522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonnucleoside HIV-1 reverse-transcriptase inhibitors, part 5. Synthesis and anti-HIV-1 activity of novel 6-naphthylthio HEPT analogues.
    Sun GF; Chen XX; Chen FE; Wang YP; De Clercq E; Balzarini J; Pannecouque C
    Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):886-92. PubMed ID: 16079514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse combinatorial design, synthesis and in vitro evaluation of new HEPT analogues as potential non-nucleoside HIV-1 reverse transcription inhibitors.
    Puig-de-la-Bellacasa R; Giménez L; Pettersson S; Pascual R; Gonzalo E; Esté JA; Clotet B; Borrell JI; Teixidó J
    Eur J Med Chem; 2012 Aug; 54():159-74. PubMed ID: 22652226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonnucleoside HIV-1 reverse transcriptase inhibitors: Part I. Synthesis and structure-activity relationship of 1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils as HEPT analogues.
    Meng G; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):779-89. PubMed ID: 12843582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR for anti-HIV activity of HEPT derivatives.
    Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
    SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition.
    Kireev DB; Chrétien JR; Grierson DS; Monneret C
    J Med Chem; 1997 Dec; 40(26):4257-64. PubMed ID: 9435895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.